Pain
Pain is, well, a pain. It is the one thing we all have direct experience of, and can communicate to others, but which defies direct… Read More »Pain
Pain is, well, a pain. It is the one thing we all have direct experience of, and can communicate to others, but which defies direct… Read More »Pain
The AI agenda is for me all about augmenting human reasoning; what I call cognology (cognitive focus) to distinguish from technology (physical focus). This is… Read More »A model for mapping machine learning onto human decision making
Dr Tim Oliver posted on the LSE Blog a thoughtful item on the various ways to understand the negotiation structure of Brexit [link to item]… Read More »UK and the EU: Brexit as failed ideology
How can I be sure the medicine I take is genuine? Counterfeit medicines are a global problem, with trade in the billions of dollars. The… Read More »Smart anti-counterfeiting: it is all in the system’s design
The King’s Fund, a UK health charity ran a scenario essay writing competition, and here is the link and of course congratulations to the winner:… Read More »Smarter and more Intelligent Healthcare in 2035
This is a summary of some emerging and salient issues related to the UK departure from the EU. Workforce It is estimated that the UK… Read More »Live short and don’t prosper: post-Brexit healthcare and life sciences
While folks have been quick to jump on the results of the referendum as evidence of democracy at work, (and perhaps that is partly true),… Read More »Patience and the political process
Continuing the theme of looking at life sciences, healthcare implications for the UK exiting the EU. The NHS, the UK’s public healthcare system, procures medicines… Read More »“I told you so”: post-Brexit access to medicines and medical device technologies
With the release of the latest analysis from the King’s Fund (here), heightened attention is being paid to NHS performance. It may only be a… Read More »When underperformance is policy
Sir Andrew Dillon, the erstwhile leader of NICE as said that it is irrational for the Cancer Drug Fund to pay for drugs that NICE… Read More »Broken logic: NICE and the Rule of Rescue